standardization of approaches when using these models for the study of immunoncology.Cancer has traditionally been treated with surgery, cytotoxic chemotherapy and/or radiotherapy. The focus of treatlknt has been the mutated neoplastic cell. Critical advances in genomic and molecular techniques herald the potential for personalized
standardization of approaches when using these models for the study of immunoncology.Cancer has traditionally been treated with surgery, cytotoxic chemotherapy and/or radiotherapy. The focus of treatlknt has been the mutated neoplastic cell. Critical advances in genomic and molecular techniques herald the potential for personalized